Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effect of Angiotensin-(1-7) on BP and HR
NCT03001271Phase 1Unknown
- Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Start
- Jan 2014
- Primary completion
- Feb 2017
- Modality
- Peptides
01
Overview
Phase 1, randomised trial of angiotensin-(1-7) in hypertension (HTN) (2 arms), sponsored by Instituto de Cardiologia do Rio Grande do Sul. Primary endpoint: Absence of adverse effects after Ang-(1-7) acute administration at 25 hours. Status: unknown.
02
Drugs
angiotensin-(1-7)
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03001271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001271.